Deutscher Allergiekongress
Sep 26 - Sep 28, 2024
- Title: Long-Term Efficacy and Safety of Oral Deucrictibant, a Bradykinin B2 Receptor Antagonist, in Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
Presenter: Emel Aygören-Pursun, M.D.
Format: e-Poster
Date, Time: Friday, Sept. 27, from 17:15 - 18:30 CEST (11:15 a.m.-12:30 p.m. EDT) - Title: Efficacy and Safety of Oral Deucrictibant, a Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
Presenter: Emel Aygören-Pursun, M.D.
Format: e-Poster
Date, time: Friday, Sept. 27, from 17:15 - 18:30 CEST (11:15 a.m.-12:30 p.m. EDT) - Title: Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema
Presenter: Markus Magerl, M.D.
Format: e-Poster
Date, Time: Friday, Sept. 27, from 17:15 - 18:30 CEST (11:15 a.m.-12:30 p.m. EDT) - Title: Characterizing Use of On-Demand Treatment Among People Living With Hereditary Angioedema in Germany
Presenter: Markus Magerl, M.D.
Format: e-Poster
Date, Time: Friday, Sept. 27, from 17:15 - 18:30 CEST (11:15 a.m.-12:30 p.m. EDT)